✦ LIBER ✦

Salivary Neurosteroid Levels and Behavioural Profiles of Children with Attention-Deficit/Hyperactivity Disorder During Six Months of Methylphenidate Treatment

✍ Scribed by Wang, Liang-Jen; Wu, Chih-Ching; Lee, Sheng-Yu; Tsai, Yi-Fang

Book ID: 127211639
Publisher: Mary Ann Liebert
Year: 2014
Tongue: English
Weight: 155 KB
Volume: 24
Category: Article
ISSN: 1044-5463
DOI: 10.1089/cap.2013.0122

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association of salivary dehydroepiandros

Association of salivary dehydroepiandrosterone levels and symptoms in patients with attention deficit hyperactivity disorder during six months of treatment with methylphenidate

✍ Liang-Jen Wang; Cheng-Cheng Hsiao; Yu-Shu Huang; Yuan-Lin Chiang; Shao-Chun Ree; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 313 KB

Reboxetine versus methylphenidate in tre

Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder

✍ Fariba Arabgol; Leily Panaghi; Paria Hebrani 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 261 KB

Methylphenidate in the Treatment of Chil

Methylphenidate in the Treatment of Children and Adolescents With Bipolar Disorder and Attention-Deficit/Hyperactivity Disorder

✍ FINDLING, ROBERT L.; SHORT, ELIZABETH J.; McNAMARA, NORA K.; DEMETER, CHRISTINE 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 127 KB

The behavioural profile of children with

The behavioural profile of children with attention-deficit/hyperactivity disorder and of their siblings

✍ Hans-Christoph Steinhausen; Nicole Zülli-Weilenmann; Daniel Brandeis; Ueli C. Mü 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 193 KB

The influence of three months of methylp

The influence of three months of methylphenidate treatment on platelet-poor plasma biogenic amine levels in boys with attention deficit hyperactivity disorder

✍ B. Spivak; Y. Vered; R. Yoran-Hegesh; E. Graff; E. Averbuch; S. Vinokurow; A. We 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 1 views

Attention deficit hyperactivity disorder (ADHD) is related to dysregulation in the activity of brain monoamines. The aim of the present study was to assess the impact of three months' methylphenidate (MPH) treatment on platelet-poor plasma (PPP) norepinephrine (NE), dopa and serotonin (5-HT) levels

Once-daily methylphenidate formulation:

Once-daily methylphenidate formulation: Impact on academic productivity and activity levels of children with attention-deficit/hyperactivity disorder

✍ S. Wigal; M. Lerner; J. Swanson 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 128 KB